Impact Factor
4.03
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.82
1,760 total citations
h5-index
45
h5 depth signal
Cited share
86.3%
339 of 393
Total citations
1,760
Citation footprint
Metric signal
4.62
External metric anchor
Self-citation
4.5%
79 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
714
China
607
Germany
173
France
159
Japan
143
Citing Fields of Research
Virology
1,417
Tropical Diseases
493
Viral Identification & Phylogenetics
487
Hepatitis
359
Immunology
268
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
9,182
Articles tracked across the journal lifetime
Indexed publication set
393
339 cited publications
Last 12 months
180
15.0 publications/month
Open access share
36.7%
66 OA publications in the last year
Leading citing country
United States
714 citing publications
Leading citing field
Virology
1,417 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n2,Jun. 1981-
v1n2,Jun. 1981-
Active Coverage
Research Focus & Classification
Indexed Subjects
Virology
Hepatitis
Viral Identification & Phylogenetics
Broad Categories
Anti-Infective Agents
Virology
Tropical Diseases
Hepatitis
Viral Identification & Phylogenetics
MeSH Descriptors
Antiviral Agents
Virus Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.antiviral.2026.106555
Open DOI
Antiviral activity of amenamevir alone and in combination with ganciclovir against equine herpesvirus 1
02
DOI 10.1016/j.antiviral.2026.106554
Open DOI
Inhibition of Porcine Cytomegalovirus/Porcine Roseolovirus (PCMV/PRV) replication with antiviral compounds
03
DOI 10.1016/j.antiviral.2026.106544
Open DOI
RNA-Dependent RNA Polymerase (RdRp): Structure, Function, and Antiviral Targeting in RNA Viruses
04
05
DOI 10.1016/j.antiviral.2026.106549
Open DOI
Meeting Report: 39th International Conference on Antiviral Research in Prague, Czech Republic, April 27–May 1, 2026
06
DOI 10.1016/j.antiviral.2026.106553
Open DOI
Toll-like receptor 7 and interferon-α synergy establishes a positive feedback loop to potentiate antiviral immunity in chronic hepatitis B
07
08
DOI 10.1016/j.antiviral.2026.106551
Open DOI
Novel phorbol-12-O-octoate derivatives exert a dual effect by inhibiting de novo HIV-1 infection and reactivating latent virus
09
DOI 10.1016/j.antiviral.2026.106552
Open DOI
Identification of novel HIV-1 capsid protein (CA) inhibitors (ACAi-010 and ACAi-024) that promote hyper-stabilization of HIV-1 CA in vitro
10
DOI 10.1016/j.antiviral.2026.106550
Open DOI
A novel antiviral drug candidate acts by binding to the hemagglutinin stem
Bibliographical & Catalog Notes
Also issued online.
Vol. 11, no. 1 (FEB 1989)19900914 Notice published Printed on acid-free paper